2026 Patients Pharma 
World of DTC Marketing
JULY 28, 2022
Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Still, the pharma industry is fighting hard to keep it off the table. Pharma is a very profitable industry. The secretary of the U.S.
European Pharmaceutical Review
AUGUST 19, 2022
billion by 2026. In addition, investigators cited the increasing geriatric patient population, growing consumption of medicines, rising healthcare expenditure, improving healthcare infrastructure in emerging markets and mounting pressure to reduce healthcare costs as other factors driving market growth. Billion by 2026, achieving a 5.6
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
SEPTEMBER 12, 2023
Over 50 percent of respondents answered that machine learning for optimisation of manufacturing processes will be the technology that will be used routinely in the pharmaceutical industry by 2026. Clinical trial patient recruitment is also primed to benefit, due to AI’s ability to analyse large datasets.
World of DTC Marketing
FEBRUARY 22, 2021
billion by 2026. Jazz Pharmaceuticals has introduced a new prescription medication for patients with sleep apnea/narcolepsy that “helped adults get up to 9 hours of improved wakefulness in clinical studies at 12 weeks” and they’re using a flying pig on their DTC. This DTC is an embaressment.
World of DTC Marketing
OCTOBER 27, 2020
Our healthcare system makes too much money for insurers, PBM’s and pharma companies to change. By 2026, national health expenditures will reach $5.7 It’s simple: people trust each other more than pharma companies who they view with a high degree of skepticism. It’s a good read but ignores a simple fact.
pharmaphorum
JANUARY 10, 2023
Its ability to accelerate R&D programmes, energise real-time clinical decision making and sharpen connections between pharma organisations and clients is clear and they can combine to positively impact patient outcomes. Pharma is a highly regulated industry and that is often why it is slow to adopt new technologies,” says Kazuki.
PM360
SEPTEMBER 28, 2022
One fast-growing group in particular that requires a patient-centric and culturally relevant approach to marketing is the Hispanic audience, which is extremely diverse. The patient landscape continues to evolve. By 2026, the U.S. A study of Hispanic patients’ U.S. Evolving Demographics. born babies are non-white.
Expert insights. Personalized for you.
256 
Let's personalize your content